Novartis delivers solid sales and core operating income growth with strong pipeline progress in Q3; reaffirms FY 2025 guidance
Novartis Q3 Results and Pipeline Progress Novartis, an innovative medicines company, delivers solid sales and core operating income growth with strong pipeline progress in Q3 and reaffirms…